$11.24 0.00 (0%)
6/3/2010 3:59 PM

Dialysis Corp of America (NASDAQ:DCAI)

CAPS Rating: No stars

The Company develops and operates outpatient kidney dialysis centers that provide quality dialysis and ancillary services to patients suffering from chronic kidney failure.

Results 1 - 4 of 4

Recs

0
Member Avatar bigmoneybastard (78.81) Submitted: 7/22/2007 11:21:22 PM : Outperform Start Price: $10.59 DCAI Score: +13.86

Good business for current demographic trends. Good entry point right now.

Recs

0
Member Avatar JDolla (66.57) Submitted: 1/5/2007 12:10:35 PM : Outperform Start Price: $13.35 DCAI Score: -17.94

Dialysis is a great business with a growing customer base and inevitably recurring revenue. This company is one of the best players in this area. Great mgmt team driving strong revenue and profit growth. They appear to have an intelligent expansion plan that is being well executed. I have been waiting for an opportunity to get into this stock once prices pulled back from an IBD driven pump/dump last year.

Recs

0
Member Avatar mschluter (< 20) Submitted: 12/14/2006 6:33:13 PM : Outperform Start Price: $12.45 DCAI Score: -10.15

There is an epidemic of diabetes; many that have it are (or will be) disadvantaged, lack proper care, and will suffer complications including kidney failure. This company has a guaranteed captive audience which will grow substatially over time.

Recs

0
Member Avatar orhein (31.99) Submitted: 10/26/2006 7:26:46 PM : Outperform Start Price: $13.97 DCAI Score: -23.06

breaking out of months long consolidation. Increasing earnings, looking good...thinly traded though

Results 1 - 4 of 4

Featured Broker Partners


Advertisement